Edition:
United States

ADMA Biologics Inc (ADMA.OQ)

ADMA.OQ on NASDAQ Stock Exchange Capital Market

5.01USD
14 Nov 2018
Change (% chg)

-- (--)
Prev Close
$5.01
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
59,103
52-wk High
$6.96
52-wk Low
$2.42

Chart for

About

ADMA Biologics, Inc. is a late-stage biopharmaceutical company that develops, manufactures and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. The Company is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. Its segments... (more)

Overall

Beta: 2.05
Market Cap(Mil.): $236.85
Shares Outstanding(Mil.): 46.35
Dividend: --
Yield (%): --

Financials

  ADMA.OQ Industry Sector
P/E (TTM): -- 80.78 29.53
EPS (TTM): -1.42 -- --
ROI: -77.84 -0.24 13.00
ROE: -241.79 -3.00 14.69

BRIEF-ADMA Biologics Files For Mixed Shelf Offering Of Up To $100 Mln

* ADMA BIOLOGICS FILES FOR MIXED SHELF OFFERING OF UP TO $100 MILLION - SEC FILING Source http://bit.ly/2IrSugh Further company coverage:

May 18 2018

BRIEF-Adma Biologics Granted U.S. Patent For Treating Respiratory Infections

* ADMA BIOLOGICS GRANTED U.S. PATENT FOR TREATING RESPIRATORY INFECTIONS

May 16 2018

Earnings vs. Estimates